Mutations and prognosis in primary myelofibrosis
2013 · Leukemia · 739 citations
https://doi.org/10.1038/leu.2013.119
R
Roberta Zini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
2.6K
Citations
26
h-index
42
i10-index
Roberta Zini is an academic researcher from MRC Centre for Regenerative Medicine. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Kruppel-like factors research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 26, co-authored 58 publications.
ORCID: 0000-0001-6657-0864Papers by this author
worksCalreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants
2019 · Scientific Reports · 63 citations
https://doi.org/10.1038/s41598-019-46843-z
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
2017 · Oncotarget · 53 citations
https://doi.org/10.18632/oncotarget.17706
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat